141 related articles for article (PubMed ID: 11533045)
1. High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2.
Tsukada Y; Miyazawa K; Kitamura N
J Biol Chem; 2001 Nov; 276(44):40968-76. PubMed ID: 11533045
[TBL] [Abstract][Full Text] [Related]
2. Involvement of down-regulation of Cdk2 activity in hepatocyte growth factor-induced cell cycle arrest at G1 in the human hepatocellular carcinoma cell line HepG2.
Tsukada Y; Tanaka T; Miyazawa K; Kitamura N
J Biochem; 2004 Nov; 136(5):701-9. PubMed ID: 15632311
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of p21CIP1 expression mediated by ERK-dependent and -independent pathways contributes to hepatocyte growth factor-induced inhibition of HepG2 hepatoma cell proliferation.
Shirako E; Hirayama N; Tsukada Y; Tanaka T; Kitamura N
J Cell Biochem; 2008 May; 104(1):176-88. PubMed ID: 18004740
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
5. Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma.
Wiesenauer CA; Yip-Schneider MT; Wang Y; Schmidt CM
J Am Coll Surg; 2004 Mar; 198(3):410-21. PubMed ID: 14992744
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor induces redistribution of p21(CIP1) and p27(KIP1) through ERK-dependent p16(INK4a) up-regulation, leading to cell cycle arrest at G1 in HepG2 hepatoma cells.
Han J; Tsukada Y; Hara E; Kitamura N; Tanaka T
J Biol Chem; 2005 Sep; 280(36):31548-56. PubMed ID: 16014626
[TBL] [Abstract][Full Text] [Related]
7. Coupling of Grb2 to Gab1 mediates hepatocyte growth factor-induced high intensity ERK signal required for inhibition of HepG2 hepatoma cell proliferation.
Kondo A; Hirayama N; Sugito Y; Shono M; Tanaka T; Kitamura N
J Biol Chem; 2008 Jan; 283(3):1428-1436. PubMed ID: 18003605
[TBL] [Abstract][Full Text] [Related]
8. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells.
Abiru S; Nakao K; Ichikawa T; Migita K; Shigeno M; Sakamoto M; Ishikawa H; Hamasaki K; Nakata K; Eguchi K
Hepatology; 2002 May; 35(5):1117-24. PubMed ID: 11981761
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma inhibits hepatocyte growth factor-stimulated cell proliferation of human bronchial epithelial cells: upregulation of p27(kip1) cyclin-dependent kinase inhibitor.
Takami K; Takuwa N; Okazaki H; Kobayashi M; Ohtoshi T; Kawasaki S; Dohi M; Yamamoto K; Nakamura T; Tanaka M; Nakahara K; Takuwa Y; Takizawa H
Am J Respir Cell Mol Biol; 2002 Feb; 26(2):231-8. PubMed ID: 11804875
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of p21/waf1 in the growth inhibition of HepG2 cells induced by hepatocyte growth factor.
Shima N; Stolz DB; Miyazaki M; Gohda E; Higashio K; Michalopoulos GK
J Cell Physiol; 1998 Oct; 177(1):130-6. PubMed ID: 9731753
[TBL] [Abstract][Full Text] [Related]
11. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
12. Effect of hepatocyte growth factor on methionine adenosyltransferase genes and growth is cell density-dependent in HepG2 cells.
Yang H; Magilnick N; Noureddin M; Mato JM; Lu SC
J Cell Physiol; 2007 Mar; 210(3):766-73. PubMed ID: 17154373
[TBL] [Abstract][Full Text] [Related]
13. Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells.
Nakagami H; Morishita R; Yamamoto K; Taniyama Y; Aoki M; Matsumoto K; Nakamura T; Kaneda Y; Horiuchi M; Ogihara T
Hypertension; 2001 Feb; 37(2 Pt 2):581-6. PubMed ID: 11230338
[TBL] [Abstract][Full Text] [Related]
14. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
15. PKC, p42/44 MAPK and p38 MAPK regulate hepatocyte growth factor secretion from human astrocytoma cells.
Chattopadhyay N; Tfelt-Hansen J; Brown EM
Brain Res Mol Brain Res; 2002 Jun; 102(1-2):73-82. PubMed ID: 12191496
[TBL] [Abstract][Full Text] [Related]
16. Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis.
Lee KH; Hyun MS; Kim JR
Clin Exp Metastasis; 2003; 20(6):499-505. PubMed ID: 14598883
[TBL] [Abstract][Full Text] [Related]
17. Single high dose irradiation induces cell cycle arrest and apoptosis in human hepatocellular carcinoma cells through the Ras/Raf/MEK/ERK pathways.
Tian X; Geng J; Zheng Q; Wang L; Huang P; Tong J; Zheng S
Int J Radiat Biol; 2020 Jun; 96(6):740-747. PubMed ID: 32039644
[No Abstract] [Full Text] [Related]
18. Phosphatidylinositol 3-kinase contributes to Erk1/Erk2 MAP kinase activation associated with hepatocyte growth factor-induced cell scattering.
Sipeki S; Bander E; Buday L; Farkas G; Bácsy E; Ways DK; Faragó A
Cell Signal; 1999 Dec; 11(12):885-90. PubMed ID: 10659996
[TBL] [Abstract][Full Text] [Related]
19. PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2.
Hu CT; Cheng CC; Pan SM; Wu JR; Wu WS
Cell Signal; 2013 Jun; 25(6):1457-67. PubMed ID: 23524339
[TBL] [Abstract][Full Text] [Related]
20. Sustained activation of extracellular signal-regulated kinase stimulated by hepatocyte growth factor leads to integrin alpha 2 expression that is involved in cell scattering.
Liang CC; Chen HC
J Biol Chem; 2001 Jun; 276(24):21146-52. PubMed ID: 11287413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
